Celcuity Reports Second Quarter 2019 Financial Results
Celcuity Inc. (CELC)
Last celcuity inc. earnings: 3/12 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
celcuity.com/home/investors
Company Research
Source: Business Wire
MINNEAPOLIS--(BUSINESS WIRE)--Celcuity Inc. (Nasdaq: CELC), a functional cellular analysis company that is discovering new cancer subtypes and commercializing diagnostic tests designed to significantly improve clinical outcomes of cancer patients treated with targeted therapies, announced financial results for the second quarter ended June 30, 2019.Unless otherwise stated, all comparisons are for the second quarter ended June 30, 2019, compared to the second quarter ended June 30, 2018.Celcuity reported a net loss of $1.72 million, or $0.17 per share, for the second quarter of 2019, compared to a net loss of $1.82 million, or $0.18 per share, for the second quarter of 2018. Net loss for the first six months of 2019 was $3.57 million, or $0.35 per share, compared to $3.78 million, or $0.37 per share, for the first six months of 2018. Non-GAAP adjusted net loss was $1.53 million, or $0.15 per share, for the second quarter of 2019, compared to non-GAAP adjusted net loss of $1.54 mill
Show less
Read more
Impact Snapshot
Event Time:
CELC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CELC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CELC alerts
High impacting Celcuity Inc. news events
Weekly update
A roundup of the hottest topics
CELC
News
- Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor ConferencesGlobeNewswire
- Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference CallGlobeNewswire
- Celcuity Inc. (NASDAQ: CELC) had its price target raised by analysts at Stifel Nicolaus from $39.00 to $42.00. They now have a "buy" rating on the stock.MarketBeat
- Celcuity Inc. (NASDAQ: CELC) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $27.00 price target on the stock.MarketBeat
- PI3K Inhibitors Market to Observe Stunning Growth During the Study Period (2020-2034) | DelveInsight [Yahoo! Finance]Yahoo! Finance
CELC
Earnings
- 8/14/24 - Beat
CELC
Analyst Actions
- 10/7/24 - Stifel
CELC
Sec Filings
- 10/25/24 - Form 4
- 10/15/24 - Form D/A
- 10/9/24 - Form 8-K
- CELC's page on the SEC website